SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study
16 references·0 citing·39 second hop
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study (2018)A prospective survey of comprehensive sco…The high price of anticancer drugs: origins, implications, barriers, solutions (2017)The high price of anticancer …The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy (2016)The association of financial …Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Measuring financial toxicity …Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Financial Insolvency as a Ris…Financial Toxicity of Cancer Care: It’s Time to Intervene (2015)Financial Toxicity of Cancer …Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study (2015)Financial toxicity in insured…Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients (2015)Financial Distress and Its As…The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)The development of a financia…Reporting and Grading Financial Toxicity (2014)Reporting and Grading Financi…Impact of Financial Burden of Cancer on Survivors' Quality of Life (2014)Impact of Financial Burden of…The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)The Financial Toxicity of Can…Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)Cost Sharing and Adherence to…Making sense of Cronbach's alpha (2011)Making sense of Cronbach's al…Japanese universal health coverage: evolution, achievements, and challenges (2011)Japanese universal health cov…Changes in Financial Burdens for Health Care (2006)Changes in Financial Burdens …A Comprehensive Method for the Translation and Cross-Cultural Validation of Health Status Questionnaires (2005)A Comprehensive Method for th…An Index of Factorial Simplicity (1974)Constructing validity: Basic issues in objective scale development. (1995)Methods for the Economic Evaluation of Health Care Programmes (2005)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay (2016)Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes (2019)Explaining income‐related inequalities in doctor utilisation in Europe (2004)What has made the population of Japan healthy? (2011)Income-Related Inequalities in Health Service Utilisation in 19 OECD Countries, 2008-2009 (2012)Consolidating the social health insurance schemes in China: towards an equitable and efficient health system (2015)Coefficient Alpha and the Internal Structure of Tests (1951)Scale Development : Theory and Applications (1991)What is coefficient alpha? An examination of theory and applications. (1993)Enhancing Student Engagement Using the Flipped Classroom (2014)Principles and methods of validity and reliability testing of questionnaires used in social and health science researches (2015)Development and initial validation of the COVID Stress Scales (2020)Translation and content analysis of oral and written materials (1980)Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines (1993)Quality of life and pharmacoeconomics in clinical trials (1996)Operacionalização de adaptação transcultural de instrumentos de aferição usados em epidemiologia (2007)Translation and validation of body image instruments: Challenges, good practice guidelines, and reporting recommendations for test adaptation (2018)Translation, Cross-Cultural Adaptation, and Validation of Measurement Instruments: A Practical Guideline for Novice Researchers (2024)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts (2013)Cumulative Impact of Sustained Economic Hardship on Physical, Cognitive, Psychological, and Social Functioning (1997)Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment (2018)Linking Clinical Variables With Health-Related Quality of Life (1995)Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes (1995)Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance (2018)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)A new scale of social desirability independent of psychopathology. (1960)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Population-Based Assessment of Cancer Survivors' Financial Burden and Quality of Life: A Prospective Cohort Study (2015)Self‐reported financial burden of cancer care and its effect on physical and mental health‐related quality of life among US cancer survivors (2016)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)
this work references cited by second hop

References

  • 2011Making sense of Cronbach's alpha15,098 cited
  • 2013The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience1,133 cited
  • 2016Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)928 cited
  • 2016Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer917 cited
  • 2005A Comprehensive Method for the Translation and Cross-Cultural Validation of Health Status Questionnaires754 cited
  • 2014The development of a financial toxicity patient‐reported outcome in cancer: The COST measure692 cited
  • 2011Japanese universal health coverage: evolution, achievements, and challenges690 cited
  • 2015Financial Toxicity of Cancer Care: It’s Time to Intervene538 cited
  • 2013Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia500 cited
  • 2014Impact of Financial Burden of Cancer on Survivors' Quality of Life472 cited
  • 2017The high price of anticancer drugs: origins, implications, barriers, solutions442 cited
  • 2015Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients234 cited
  • 2015Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study216 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2006Changes in Financial Burdens for Health Care201 cited
  • 2016The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy160 cited
  • 2014Reporting and Grading Financial Toxicity80 cited
  • Cited by

    No citing works inside the corpus for this window.